ctrl K

Watchlist Price Alert

Monte Rosa Therapeutics I... (GLUE)

NASDAQ: GLUE · Real-Time Price · USD

4.64

-0.18 (-3.73%)

At close: Jun 17, 2025, 2:22 PM

Monte Rosa Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	75.62M	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	6.22M	8.56M	2.13M	537K	72K
Gross Profit	67.5M	-6.22M	-8.56M	-2.13M	-537K	-72K
Operating Income	-81.11M	-143.31M	-112.38M	-72.88M	-28.01M	-7.99M
Interest Income	10.57M	9.33M	3.76M	46K	9K	12.00
Pretax Income	-70.13M	-135.01M	-108.5M	-73.96M	-35.88M	-7.74M
Net Income	-72.7M	-135.35M	-104.62M	-71.94M	-36.07M	-8.02M
Selling & General & Admin	35.17M	32.04M	27.32M	15.73M	4M	644K
Research & Development	121.56M	105.05M	85.06M	57.16M	24M	7.35M
Other Expenses	n/a	n/a	n/a	-960K	-7.68M	276K
Operating Expenses	156.73M	143.31M	112.38M	72.88M	28.01M	7.99M
Interest Expense	n/a	n/a	3.76M	n/a	n/a	1K
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	156.73M	143.31M	112.38M	72.88M	28.01M	7.99M
Income Tax Expense	2.57M	338K	-3.88M	-2.02M	189K	277K
Shares Outstanding (Basic)	73.91M	51.4M	47.23M	46.54M	44M	44M
Shares Outstanding (Diluted)	73.91M	51.4M	47.23M	46.54M	44M	44M
EPS (Basic)	-0.98	-2.63	-2.22	-1.55	-0.82	-0.18
EPS (Diluted)	-0.98	-2.63	-2.22	-1.55	-0.82	-0.18
EBITDA	-72.99M	-137.09M	-99.94M	-70.75M	-27.47M	-7.67M
EBIT	-81.11M	-143.31M	-112.38M	-73.96M	-28.01M	-7.74M
Depreciation & Amortization	8.12M	6.22M	8.56M	2.13M	537K	72K